RxDoctor Payments Data

John Gore, MD

Urology · Seattle, WANPI 1265553374

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.6%), education and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Intuitive Surgical at 39.5% of the total. Reporting peaked in 2021 at $6,550 and has fallen 82.4% since, to $1,155 in 2025. Among urology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,495in general payments, 2019–2025

Across 24 payments — averaging $603.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • Janssen Global Services, LLC$4K
  • Seagen Inc.$3K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Astellas Pharma Global Development$625
  • Urogen Pharma, Inc.$171
  • plus $116 from 2 others
$100,037in research payments, 2019–2025

Across 23 payments — averaging $4349.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Photocure Inc$82K
  • Merck$18K
  • Urogen Pharma, Inc.$352

What the payments were for

  • Consulting fees$8,35058%
  • Speaking & faculty fees$1,50010%
  • Travel & lodging$3132%
  • Food & beverage$1,3329%
  • Education$3,00021%

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,495 in reported general payments places this provider in the 90th percentile of 274 urology providers in Washington.

See all urology providers in Washington

Medicare billing

Part B allowed, 2024
$127,074
Medicare patients
287
Services billed
729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron34$24,953
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$1,652
Tamsulosin Hcl94$1,518
Trospium Chloride ErTrospium Chloride11$989
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$743
Finasteride40$580
Dutasteride14$345
Alfuzosin Hcl ErAlfuzosin Hcl13$320
Oxybutynin Chloride12$269

Paid to pharmacies, not to this prescriber.

Other urology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →